Breadcrumb Home Media centre Media releases Media Releases Quick Explore In the news Featured Stories Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune Cipla Foundation awards scholarships to students from Goa College of Pharmacy #InhalersHainSahi - #BerokZindagi is back to inspire people with asthma to live a life without limits Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India Year 2020201920182017201620152014201320122010 Search News Apply Media Releases 2020 Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease Cipla expands partnership with Roche Pharma India to further improve access to key oncology medicines Cipla receives final approval for generic version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) with a Competitive Generic Therapy Designation Cipla files ANDA for generic version of GSK’s Advair Diskus® Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment Cipla stands strong with India in the battle against COVID-19 Cipla receives final approval for generic version of Proventil® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation) Cipla announces successful completion of Phase-3 clinical study for generic version of GSK’s Advair Diskus® Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg) Cipla Expands Women’s Health Portfolio through Acquisition of 4 Key Brands from Wanbury Cipla Foundation sets up a dedicated state-of-the-art chemistry laboratory at IISER Pune
